Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 16 January, 2020

Citadel Group

Form 8.3 - Allergan plc

RNS Number : 0146A
Citadel Group
16 January 2020
 


























 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION




























Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common ISIN IE00BY9D5467

Date of dealing

15 January, 2020



























2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)









Long

Short

Common Stock  ISIN  IE00BY9D5467

Number        (%)

Number      (%)

(1) Relevant securities

752,678 (0.23%)

9,855 (0.00%)

(2) Derivatives (other than options)

3,780,026 (1.15%)

9,226 (0.00%)

(3) Options and agreements to purchase/sell

0 (0.00%)

310,200 (0.09%)

Total

4,532,704(1.38%)

329,281 (0.10%)




























 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


























Long

Short


Number        (%)

Number      (%)

(1) Relevant securities



(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total

































Ap 20
































1.         DEALINGS (Note 4)

 

(a)        Purchases and sales































Purchase/sale

Common Stock ISIN IE00BY9D5467

Number of securities

Price per unit (Note 5)

a buy

145

193.85  USD

a sell

-145

193.85  USD

Purchase

100

192.83  USD

Purchase

100

192.88  USD

Purchase

100

193  USD

Purchase

100

193.01  USD

Purchase

500

193.05  USD

Purchase

100

193.08  USD

Purchase

820

193.09  USD

Purchase

100

193.1  USD

Purchase

100

193.12  USD

Purchase

100

193.16  USD

Purchase

100

193.17  USD

Purchase

115

193.2  USD

Purchase

100

193.32  USD

Purchase

49

193.34  USD

Purchase

850

193.47  USD

Purchase

20

193.48  USD

Purchase

205

193.49  USD

Purchase

300

193.51  USD

Purchase

68

193.52  USD

Purchase

133

193.53  USD

Purchase

303

193.58  USD

Purchase

417

193.59  USD

Purchase

100

193.6  USD

Purchase

418

193.61  USD

Purchase

10

193.62  USD

Purchase

131

193.63  USD

Purchase

219

193.64  USD

Purchase

200

193.7  USD

Purchase

110

193.71  USD

Purchase

209

193.72  USD

Purchase

140

193.77  USD

Purchase

397

193.78  USD

Purchase

1

193.815  USD

Purchase

403

193.82  USD

Purchase

100

193.84  USD

Purchase

145

193.85  USD

Purchase

1,749

193.85  USD

Purchase

100

193.92  USD

Purchase

100

194.04  USD

Purchase

10

194.4  USD

Purchase

100

194.41  USD

Purchase

80

194.5  USD

Sale

-115

192.85  USD

Sale

-98

192.91  USD

Sale

-100

192.94  USD

Sale

-400

192.97  USD

Sale

-100

192.98  USD

Sale

-200

193.07  USD

Sale

-300

193.09  USD

Sale

-84

193.1  USD

Sale

-101

193.14  USD

Sale

-100

193.15  USD

Sale

-300

193.16  USD

Sale

-200

193.17  USD

Sale

-200

193.18  USD

Sale

-110

193.2  USD

Sale

-100

193.21  USD

Sale

-332

193.22  USD

Sale

-100

193.24  USD

Sale

-100

193.25  USD

Sale

-100

193.27  USD

Sale

-100

193.28  USD

Sale

-200

193.29  USD

Sale

-29

193.3  USD

Sale

-100

193.32  USD

Sale

-300

193.33  USD

Sale

-188

193.34  USD

Sale

-450

193.38  USD

Sale

-196

193.4  USD

Sale

-202

193.48  USD

Sale

-272

193.49  USD

Sale

-300

193.5  USD

Sale

-201

193.51  USD

Sale

-1,000

193.56  USD

Sale

-338

193.6  USD

Sale

-701

193.62  USD

Sale

-152

193.68  USD

Sale

-200

193.7  USD

Sale

-300

193.72  USD

Sale

-200

193.73  USD

Sale

-133

193.74  USD

Sale

-200

193.75  USD

Sale

-202

193.77  USD

Sale

-179,067

193.7886  USD

Sale

-311

193.7886  USD

Sale

-197

193.82  USD

Sale

-100

193.87  USD

Sale

-300

193.88  USD

Sale

-150

193.89  USD

Sale

-101

193.91  USD

Sale

-601

193.92  USD

Sale

-140

193.95  USD

Sale

-200

193.97  USD

Sale

-100

193.99  USD

Sale

-100

194  USD

Sale

-186

194.01  USD

Sale

-200

194.03  USD

Sale

-323

194.06  USD

Sale

-685

194.09  USD

Sale

-300

194.1  USD

Sale

-100

194.14  USD

Sale

-63

194.19  USD

Sale

-100

194.32  USD

Sale

-200

194.34  USD

Sale

-100

194.35  USD

Sale

-200

194.37  USD






















(b)        Derivatives transactions (other than options transactions)
























Product name,

e.g. CFD

 ISIN

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)


























(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying

























Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)

Put Option

Purchasing

-59100

160 USD

American

2/21/2020

USD





















(ii)        Exercising

























Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)
































(d)        Other dealings (including transactions in respect of new securities) (Note 4)






























Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)










 



















Ap 21

















2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
















Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None














Is a Supplemental Form 8 attached? (Note 9)


YES

















 Date of disclosure:

16 January, 2020

 Contact name:

Katie Bonds

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a





 








Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 











Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Put Option

Purchased

-200,000

160 USD

American

2/21/2020

Put Option

Purchased

-110,200

180 USD

American

1/17/2020












Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs),  full details should be given. Full details of any existing agreements to urchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.








 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEKZGMMRVNGGZG

a d v e r t i s e m e n t